Alonso AD, Beharry C, Corbo CP, Cohen LS (2016) Molecular mechanism of prion-like tau-induced neurodegeneration. Alzheimers Dement 12(10):1090–1097
PubMed
Google Scholar
Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ et al (2006) Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281:29739–29752
CAS
PubMed
Google Scholar
Bartels T, Choi JG, Selkoe DJ (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107–110
CAS
PubMed
PubMed Central
Google Scholar
Castillo-Carranza DL, Guerrero-Muñoz MJ, Sengupta U, Gerson JE, Kayed R (2018) α-Synuclein oligomers induce a unique toxic tau strain. Biol Psychiatry 84:499–508
CAS
PubMed
PubMed Central
Google Scholar
Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic interactions between Aβ, tau, and α-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30:7281–7289
CAS
PubMed
PubMed Central
Google Scholar
Credle JJ, George JL, Wills J, Duka V, Shah K, Lee YC et al (2015) GSK-3β dysregulation contributes to Parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein. Cell Death Differ 22:838–851
CAS
PubMed
Google Scholar
Cremades N, Cohen S, Deas E, Abramov A, Chen A, Orte A et al (2012) Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 149:1048–1059
CAS
PubMed
PubMed Central
Google Scholar
DeVos SL, Corjuc BT, Commins C, Dujardin S, Bannon RN, Corjuc D et al (2018) Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo. Brain 141(7):2194–2212
PubMed
PubMed Central
Google Scholar
Duka T, Duka V, Joyce JN, Sidhu A (2009) α-Synuclein contributes to GSK-3β-catalyzed tau phosphorylation in Parkinson's disease models. FASEB J 23:2820–2830
CAS
PubMed
PubMed Central
Google Scholar
Duka V, Lee JH, Credle J, Wills J, Oaks A, Smolinsky C et al (2013) Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer’s diseases. PLoS One 8:e75025
CAS
PubMed
PubMed Central
Google Scholar
Fiorini M, Bongianni M, Monaco S, Zanusso G (2017) Biochemical characterization of prions. Prog Mol Biol Transl Sci 150:389–407
PubMed
Google Scholar
Forloni G, Artuso V, La Vitola P, Balducci C (2016) Oligomeropathies and pathogenesis of Alzheimer and Parkinson’s diseases. Mov Disord 31:771–781
CAS
PubMed
Google Scholar
Frasier M, Walzer M, McCarthy L, Magnuson D, Lee JM, Haas C et al (2005) Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein. Exp Neurol 192:274–287
CAS
PubMed
Google Scholar
Fukasawa N, Fukuda T, Nagaoka M, Harada T, Takahashi H, Ikegami M (2018) Aggregation and phosphorylation of α-synuclein with proteinase K resistance in focal α-synucleinopathy predominantly localized to the cardiac sympathetic nervous system. Neuropathol Appl Neurobiol 44(3):341–344
CAS
PubMed
Google Scholar
Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT et al (2003) Initiation and synergistic fibrillization of tau and α-synuclein. Science 300:636–640
CAS
PubMed
Google Scholar
Golpich M, Amini E, Hemmati F, Ibrahim NM, Rahmani B, Mohamed Z et al (2015) Glycogen synthase kinase-3β (GSK-3β) signaling: implications for Parkinson’s disease. Pharmacol Res 97:16–26
CAS
PubMed
Google Scholar
Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B et al (2013) Distinct α-synuclein strains differentially promote tau inclusions in neurons. Cell 154:103–117
CAS
PubMed
Google Scholar
Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E et al (2011) Hyperphosphorylated tau in an α-synuclein overexpressing transgenic model of Parkinson's disease. Eur J Neurosci 33:1598–1610
PubMed
PubMed Central
Google Scholar
Hanger DP, Anderton BH, Noble W (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 15(3):112–119
CAS
PubMed
Google Scholar
Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX et al (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55–65
PubMed
PubMed Central
Google Scholar
Iwatsubo T (2007) Pathological biochemistry of α-synucleinopathy. Neuropathology 27:474–478
PubMed
Google Scholar
Jackson GR (2018) Lifestyles of a toxic twosome: a novel tau strain induced by α-synuclein oligomers. Biol Psychiatry 84:472–473
PubMed
Google Scholar
Jensen PH, Hager H, Nielsen MS, Hojrup P, Gliemann J, Jakes R (1999) α-Synuclein binds to tau and stimulates the protein kinase a-catalyzed tau phosphorylation of serine residues 262 and 356. J Biol Chem 274:25481–25489
CAS
PubMed
Google Scholar
Kazee AM, Han LY (1995) Cortical Lewy bodies in Alzheimer's disease. Arch Pathol Lab Med 119:448–453
CAS
PubMed
Google Scholar
Khandelwal PJ, Dumanis SB, Feng LR, Maguire-Zeiss K, Rebeck G, Lashuel HA et al (2010) Parkinson-related parkin reduces α-synuclein phosphorylation in a gene transfer model. Mol Neurodegener 5:47
PubMed
PubMed Central
Google Scholar
Khandelwal PJ, Dumanis SB, Herman AM, Rebeck GW, Moussa CE (2012) Wild type and P301L mutant tau promote neuro-inflammation and α-synuclein accumulation in lentiviral gene delivery models. Mol Cell Neurosci 49:44–53
CAS
PubMed
Google Scholar
Kins S, Crameri A, Evans DR, Hemmings BA, Nitsch RM, Gotz J (2001) Reduced PP2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J Biol Chem 276:38193–38200
CAS
PubMed
Google Scholar
Kraybill ML, Larson EB, Tsuang DW, Teri L, McCormick WC, Bowen JD et al (2005) Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology 64:2069–2073
CAS
PubMed
PubMed Central
Google Scholar
Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38–48
CAS
PubMed
PubMed Central
Google Scholar
Lewis J, Dickson DW (2016) Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:27–48
CAS
PubMed
Google Scholar
Li X, James S, Lei P (2016) Interactions between α-synuclein and tau protein: implications to neurodegenerative disorders. J Mol Neurosci 60:298–304
CAS
PubMed
Google Scholar
Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML et al (1998) Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer’s disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153:1365–1370
CAS
PubMed
PubMed Central
Google Scholar
Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Yardin C et al (2013) Tau protein kinases: involvement in Alzheimer's disease. Ageing Res Rev 12(1):289–309
CAS
PubMed
Google Scholar
Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H et al (2013) Prion-like spreading of pathological α-synuclein in brain. Brain 136(Pt 4):1128–1138
PubMed
PubMed Central
Google Scholar
Mbefo MK, Paleologou KE, Boucharaba A, Oueslati A, Schell H, Fournier M et al (2010) Phosphorylation of α-synucleins by members of the polo-like kinase family. J Biol Chem 285:2807–2822
CAS
PubMed
Google Scholar
McKenzie-Nickson S, Chan J, Perez K, Hung LW, Cheng L, Sedjahtera A et al (2018) Modulating protein phosphatase 2A rescues disease phenotype in neurodegenerative tauopathies. ACS Chem Neurosci 9(11):2731–2740
CAS
PubMed
Google Scholar
Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, Spooren W et al (2002) Misfolded proteinase K-resistant hyperphosphorylated α-synuclein in aged transgenic mice with locomotor deterioration and in human α-synucleinopathies. J Clin Invest 110(10):1429–1439
CAS
PubMed
PubMed Central
Google Scholar
Neumann M, Müller V, Kretzschmar HA, Haass C, Kahle PJ (2004) Regional distribution of proteinase K-resistant α-synuclein correlates with Lewy body disease stage. J Neuropathol Exp Neurol 63(12):1225–1235
CAS
PubMed
Google Scholar
Nonaka T, Masuda-Suzukake M, Hasegawa M (2018) Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases. Neuropathology 38:64–71
CAS
PubMed
Google Scholar
Norwitz NG, Mota AS, Norwitz SG, Clarke K (2019) Multi-loop model of Alzheimer disease: an integrated perspective on the Wnt/GSK-3β, α-synuclein, and type 3 diabetes hypotheses. Front Aging Neurosci 11:184
CAS
PubMed
PubMed Central
Google Scholar
Oikawa T, Nonaka T, Terada M, Tamaoka A, Hisanaga S, Hasegawa M (2016) α-Synuclein fibrils exhibit gain of toxic function, promoting tau aggregation and inhibiting microtubule assembly. J Biol Chem 291(29):15046–15056
CAS
PubMed
PubMed Central
Google Scholar
Olichney JM, Galasko D, Salmon DP (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 51:351–357
CAS
PubMed
Google Scholar
Ono K (2017) The oligomer hypothesis in α-synucleinopathy. Neurochem Res 42(12):3362–3371
CAS
PubMed
Google Scholar
Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F et al (2008) Formation of toxic oligomeric α-synuclein species in living cells. PLoS One 3(4):e1867
PubMed
PubMed Central
Google Scholar
Palomer E, Buechler J, Salinas PC (2019) Wnt signaling deregulation in the aging and Alzheimer's brain. Front Cell Neurosci 13:227
CAS
PubMed
PubMed Central
Google Scholar
Rey NL, George S, Brundin P (2016) Review: spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of α-synuclein. Neuropathol Appl Neurobiol 42:51–76
CAS
PubMed
Google Scholar
Roostaee A, Beaudoin S, Staskevicius A, Roucou X (2013) Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization. Mol Neurodegener 8:5
CAS
PubMed
PubMed Central
Google Scholar
Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M et al (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309(5733):476–481
CAS
PubMed
PubMed Central
Google Scholar
Spires TL, Orne JD, SantaCruz K, Pitstick R, Carlson GA, Ashe KH et al (2006) Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol 168(5):1598–1607
CAS
PubMed
PubMed Central
Google Scholar
Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134:187–205
CAS
PubMed
PubMed Central
Google Scholar
Stephano F, Nolte S, Hoffmann J, El-Kholy S, Von Frieling J, Bruchhaus I et al (2018) Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson’s disease model. Sci Rep 8:2372
PubMed
PubMed Central
Google Scholar
Takaichi Y, Ano Y, Chambers JK, Uchida K, Takashima A, Nakayama H (2018) Deposition of phosphorylated α-synuclein in the rTg4510 mouse model of tauopathy. J Neuropathol Exp Neurol 77(10):920–928
CAS
PubMed
Google Scholar
Tanji K, Mori F, Mimura J, Itoh K, Kakita A, Takahashi H et al (2010) Proteinase K-resistant α-synuclein is deposited in presynapses in human Lewy body disease and A53T α-synuclein transgenic mice. Acta Neuropathol 120(2):145–154
CAS
PubMed
Google Scholar
Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M et al (2010) Brain α-synuclein accumulation in multiple system atrophy, Parkinson’s disease and progressive supranuclear palsy: a comparative investigation. Brain 133:172–188
PubMed
Google Scholar
Tu S, Okamoto S, Lipton SA, Xu H (2014) Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease. Mol Neurodegener 9:48
PubMed
PubMed Central
Google Scholar
Wills J, Credle J, Haggerty T, Lee JH, Oaks AW, Sidhu A (2011) Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease. PLoS One 6(3):e17953
CAS
PubMed
PubMed Central
Google Scholar
Xu Y, Deng Y, Qing H (2015) The phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson’s disease. J Neurochem 135:4–18
CAS
PubMed
Google Scholar
Yancopoulou D, Xuereb JH, Crowther RA, Hodges JR, Spillantini MG (2005) Tau and α-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia. J Neuropathol Exp Neurol 64:245–253
CAS
PubMed
Google Scholar
Yuan YH, Yan WF, Sun JD, Huang JY, Mu Z, Chen NH (2015) The molecular mechanism of rotenone-induced α-synuclein aggregation: emphasizing the role of the calcium/GSK-3β pathway. Toxicol Lett 233:163–171
CAS
PubMed
Google Scholar